Recruiting
Phase 1

HBOT

Sponsor:

Paul G. Harch, M.D.

Code:

NCT00592891

Conditions

Adult and Pediatric Chronic Cerebral Disorders

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Hyperbaric oxygen therapy

Study Details

Brief summary:

Hypothesis: That HBOT can be toxic in the low-pressure range.

Conditions

Adult and Pediatric Chronic Cerebral Disorders

Study ID

NCT00592891

Start date

Apr, 2002

Status verified date

Jan, 2015

Completion date

Dec, 2016

Anticipated

Primary completion date

Dec, 2016

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Cerebral disorder of greater than one year's duration

Exclusion Criteria:

  • None

Study Design

Enrollment

45 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Hyperbaric oxygen therapy

Patients undergoing low pressure HBOT for chronic brain injury

Interventions

Hyperbaric oxygen therapy

Total body pressurized oxygen

Primary outcome measure

  • Oxygen toxicity [ Time Frame: After completion of hyperbaric oxygen therapy ]

Central Contacts and Locations

Central contacts

Paul G Harch, M.D.

504-309-4948paulharchmd@gmail.com

Locations

Family Physicians Center

Recruiting

Marrero, Louisiana, United States, 70072

Contacts

Paul G Harch, M.D.

504-309-4948paulharchmd@gmail.com

Principal Investigator:

Paul G Harch, M.D.

More Information

Sponsor

Paul G. Harch, M.D.

Last update posted

Jan 5, 2015

Last verified

Jan, 2015

Keywords

  • brain injury
  • brain disorders

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Paul G. Harch, M.D. on 2015-01-05.